SSRIs for mild cognitive impairment to Alzheimer’s disease
Could selective serotonin reuptake inhibitors (SSRIs) help reduce the burden of Alzheimer’s disease and prevent decline from mild cognitive impairment?
An estimated 10% of people...
On the ground in Mallacoota: community pharmacy at the front line
Images of holidaymakers being evacuated by Navy ship as bushfires closed in on Mallacoota have made the Victorian coastal town a global symbol of...
Research winners for PSA18
Researchers examining polypharmacy within aged populations have won the best paper and best poster categories at PSA18.
Lauren Corre and a team of University of...
Managing gastrointestinal problems in infants
Opting for a better approach.
Proton pump inhibitors (PPIs) were developed in the 1980s. Omeprazole, the first to be marketed, is on the WHO Model...
Medicine safety in aged care must be improved
One in five unplanned hospital admissions for aged care residents is the result of inappropriate medicines use, a new report from PSA reveals.
What you missed at PSA22 – Day 1
PSA22 kicked off with a bang, with a day full of major announcements, therapeutic updates, and policy and practice insights.


Deborah Williams at the Chemist Warehouse Australian Open pop-up pharmacy[/caption]


Rebecca Davies[/caption]

Professor Clare Collins[/caption]
Associate Professor Trevor Steward[/caption]









